| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A single-cell atlas identifies pretreatment features of primary imatinib resistance in chronic myeloid leukemia
|
Krishnan, Vaidehi
|
|
|
141 |
22 |
p. 2738-2755
|
article
|
| 2 |
Back Matter
|
|
|
|
141 |
22 |
p. I
|
article
|
| 3 |
Cole O, King AA. iTPP: nature vs nurture? Blood. 2022;140(12):1329-1330.
|
|
|
|
141 |
22 |
p. 2786
|
article
|
| 4 |
DOCK11 deficiency in patients with X-linked actinopathy and autoimmunity
|
Boussard, Charlotte
|
|
|
141 |
22 |
p. 2713-2726
|
article
|
| 5 |
Editorial Board
|
|
|
|
141 |
22 |
p. x
|
article
|
| 6 |
Help on the way to unsilence HbF
|
Dean, Ann
|
|
|
141 |
22 |
p. 2670-2672
|
article
|
| 7 |
How I diagnose and treat neonatal thrombocytopenia
|
Stanworth, Simon J.
|
|
|
141 |
22 |
p. 2685-2697
|
article
|
| 8 |
Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents
|
Spinner, Michael A.
|
|
|
141 |
22 |
p. 2727-2737
|
article
|
| 9 |
Improved survival in cHL with novel agents
|
Merryman, Reid W.
|
|
|
141 |
22 |
p. 2666-2668
|
article
|
| 10 |
Kemps PG, Picarsic J, Durham BH, et al. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. Blood. 2022;139(2):256-280.
|
|
|
|
141 |
22 |
p. 2785-2786
|
article
|
| 11 |
Masthead Subscription
|
|
|
|
141 |
22 |
p. i
|
article
|
| 12 |
Molecular basis of polycomb group protein–mediated fetal hemoglobin repression
|
Qin, Kunhua
|
|
|
141 |
22 |
p. 2756-2770
|
article
|
| 13 |
Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma
|
Santoro, Armando
|
|
|
141 |
22 |
p. 2780-2783
|
article
|
| 14 |
Novel biomarker-based probability engine
|
Inamoto, Yoshihiro
|
|
|
141 |
22 |
p. 2672-2673
|
article
|
| 15 |
Novel extragenic genomic safe harbors for precise therapeutic T-cell engineering
|
Odak, Ashlesha
|
|
|
141 |
22 |
p. 2698-2712
|
article
|
| 16 |
Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysis
|
Socié, Gerard
|
|
|
141 |
22 |
p. 2771-2779
|
article
|
| 17 |
Single cells tell multiple tales in CML
|
Ross, David M.
|
|
|
141 |
22 |
p. 2668-2670
|
article
|
| 18 |
Splendid isolation
|
Wagner, Dimitrios Laurin
|
|
|
141 |
22 |
p. 2665-2666
|
article
|
| 19 |
Table of Contents
|
|
|
|
141 |
22 |
p. iii-v
|
article
|
| 20 |
Targeted therapy in mediastinal gray zone lymphoma
|
Kuruvilla, John
|
|
|
141 |
22 |
p. 2673-2674
|
article
|
| 21 |
Targeting biased signaling by PAR1: function and molecular mechanism of parmodulins
|
Künze, Georg
|
|
|
141 |
22 |
p. 2675-2684
|
article
|
| 22 |
VEXAS’d by lymphadenopathy: an unusual case of extramedullary hematopoiesis
|
Fenu, Elena M.
|
|
|
141 |
22 |
p. 2784
|
article
|
Journal description